170 related articles for article (PubMed ID: 12569086)
1. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
Iida KT; Kawakami Y; Suzuki M; Shimano H; Toyoshima H; Sone H; Shimada K; Iwama Y; Watanabe Y; Mokuno H; Kamata K; Yamada N
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1125-30. PubMed ID: 12569086
[TBL] [Abstract][Full Text] [Related]
2. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
3. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R
Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients.
Cominacini L; Garbin U; Fratta Pasini A; Campagnola M; Davoli A; Foot E; Sighieri G; Sironi AM; Lo Cascio V; Ferrannini E
Diabetes; 1998 Jan; 47(1):130-3. PubMed ID: 9421387
[TBL] [Abstract][Full Text] [Related]
7. Synergistic actions of insulin and troglitazone on contractility in endothelium-denuded rat aortic rings.
Goud C; Pitt B; Webb RC; Richey JM
Am J Physiol; 1998 Nov; 275(5):E882-7. PubMed ID: 9815009
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
9. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.
Mathieu-Costello O; Kong A; Ciaraldi TP; Cui L; Ju Y; Chu N; Kim D; Mudaliar S; Henry RR
Metabolism; 2003 May; 52(5):540-6. PubMed ID: 12759881
[TBL] [Abstract][Full Text] [Related]
10. Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1.
Sachidanandam K; Harris A; Hutchinson J; Ergul A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1016-21. PubMed ID: 16741041
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats.
Kosegawa I; Chen S; Awata T; Negishi K; Katayama S
Clin Exp Hypertens; 1999 Apr; 21(3):199-211. PubMed ID: 10225476
[TBL] [Abstract][Full Text] [Related]
12. Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum.
Paskaloglu K; Sener G; Ayanğolu-Dülger G
Eur J Pharmacol; 2004 Sep; 499(3):345-54. PubMed ID: 15381057
[TBL] [Abstract][Full Text] [Related]
13. Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta.
Ozansoy G; Akin FB
J Pharm Pharmacol; 2004 Feb; 56(2):241-6. PubMed ID: 15005883
[TBL] [Abstract][Full Text] [Related]
14. Effect of melatonin on vascular responses in aortic rings of aging rats.
Reyes-Toso CF; Obaya-Naredo D; Ricci CR; Planells FM; Pinto JE; Linares LM; Cardinali DP
Exp Gerontol; 2007 Apr; 42(4):337-42. PubMed ID: 17116384
[TBL] [Abstract][Full Text] [Related]
15. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.
Rösen P; Wiernsperger NF
Diabetes Metab Res Rev; 2006; 22(4):323-30. PubMed ID: 16444763
[TBL] [Abstract][Full Text] [Related]
16. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
19. [The beneficial effect of natural antioxidants on the endothelial function of regenerated endothelium].
Cartier R; Bouchard D
Ann Chir; 1998; 52(8):827-33. PubMed ID: 9846436
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells.
Solomon SS; Mishra SK; Cwik C; Rajanna B; Postlethwaite AE
Horm Metab Res; 1997 Aug; 29(8):379-82. PubMed ID: 9288574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
